• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

139
23
13
13
12

COUNTRY

12
7
4
3
2

PRICE

572
602
742
885

PUBLISHED

2
3
84
885

PRODUCT TYPE

486
398
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Lupus Nephritis - Pipeline Review, H1 2014

Lupus Nephritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2014’, provides an overview of the Lupus Nephritis’s therapeutic pipeline. This...

March 2014
FROM

Severe Psoriasis - Pipeline Review, H1 2014

Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This...

March 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014’, provides an overview of the Graft Versus...

March 2014
FROM

Liver Transplantation - Pipeline Review, H1 2014

Liver Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liver Transplantation - Pipeline Review, H1 2014’, provides an overview of the Liver Transplantation’s therapeutic...

February 2014
FROM

Peanut Allergy - Pipeline Review, H1 2014

Peanut Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peanut Allergy - Pipeline Review, H1 2014’, provides an overview of the Peanut Allergy’s therapeutic pipeline. This report...

February 2014
FROM

Psoriasis - Pipeline Review, H1 2014

Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014’, provides an overview of the Plaque...

February 2014
FROM

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This...

February 2014
FROM

Osteoarthritis - Pipeline Review, H1 2014

Osteoarthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2014’, provides an overview of the Osteoarthritis’s therapeutic pipeline. This report...

February 2014
FROM

Systemic Lupus Erythematosus - Pipeline Review, H1 2014

Systemic Lupus Erythematosus - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2014’, provides an overview of the Systemic Lupus Erythematosus’s...

February 2014
FROM

Lung Transplantation - Pipeline Review, H1 2014

Lung Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, 'Lung Transplantation - Pipeline Review, H1 2014', provides an overview of the indication’s therapeutic pipeline. This...

January 2014
FROM

Humira (Crohn's Disease) - Forecast and Market Analysis to 2022

Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will...

January 2014
FROM

Entyvio (Crohn's Disease) - Forecast and Market Analysis to 2022

Entyvio (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will...

January 2014
FROM

PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - Canada Drug Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These...

January 2014
FROM

Cimzia (Crohn's Disease) - Forecast and Market Analysis to 2022

Cimzia (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will...

January 2014
FROM

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

Vercirnon (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds...

January 2014
FROM

PharmaPoint: Crohn's Disease - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - Japan Drug Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These...

January 2014
FROM

Lupus Nephritis Global Clinical Trials Review, H1, 2014

Lupus Nephritis Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2014" provides data on the Lupus Nephritis clinical trial...

January 2014
FROM

PharmaPoint: Crohn's Disease - China Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - China Drug Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These...

January 2014
FROM

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022

Prochymal (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds...

January 2014
FROM
Loading Indicator

Our Clients

Our clients' logos